111 related articles for article (PubMed ID: 31860798)
21. The first sphingosine 1-phosphate lyase inhibitors against multiple sclerosis: a successful drug discovery tale.
Cosconati S; Novellino E
J Med Chem; 2014 Jun; 57(12):5072-3. PubMed ID: 24913310
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and antibacterial activity of mechanism-based inhibitors of KDO8P synthase and DAH7P synthase.
Grison C; Petek S; Finance C; Coutrot P
Carbohydr Res; 2005 Mar; 340(4):529-37. PubMed ID: 15721322
[TBL] [Abstract][Full Text] [Related]
23. Active-site engineering of benzaldehyde lyase shows that a point mutation can confer both new reactivity and susceptibility to mechanism-based inhibition.
Brandt GS; Kneen MM; Petsko GA; Ringe D; McLeish MJ
J Am Chem Soc; 2010 Jan; 132(2):438-9. PubMed ID: 20030408
[TBL] [Abstract][Full Text] [Related]
24. Sphingosine-phosphate lyase enhances stress-induced ceramide generation and apoptosis.
Reiss U; Oskouian B; Zhou J; Gupta V; Sooriyakumaran P; Kelly S; Wang E; Merrill AH; Saba JD
J Biol Chem; 2004 Jan; 279(2):1281-90. PubMed ID: 14570870
[TBL] [Abstract][Full Text] [Related]
25. Assay to measure the secretion of sphingosine-1-phosphate from cells induced by S1P lyase inhibitors.
Loetscher E; Schneider K; Beerli C; Billich A
Biochem Biophys Res Commun; 2013 Apr; 433(3):345-8. PubMed ID: 23499842
[TBL] [Abstract][Full Text] [Related]
26. Catalytic action of fuculose 1-phosphate aldolase (class II) as derived from structure-directed mutagenesis.
Joerger AC; Gosse C; Fessner WD; Schulz GE
Biochemistry; 2000 May; 39(20):6033-41. PubMed ID: 10821675
[TBL] [Abstract][Full Text] [Related]
27. A rapid fluorescence assay for sphingosine-1-phosphate lyase enzyme activity.
Bandhuvula P; Fyrst H; Saba JD
J Lipid Res; 2007 Dec; 48(12):2769-78. PubMed ID: 17872591
[TBL] [Abstract][Full Text] [Related]
28. Characterization of homologous sphingosine-1-phosphate lyase isoforms in the bacterial pathogen Burkholderia pseudomallei.
McLean CJ; Marles-Wright J; Custodio R; Lowther J; Kennedy AJ; Pollock J; Clarke DJ; Brown AR; Campopiano DJ
J Lipid Res; 2017 Jan; 58(1):137-150. PubMed ID: 27784725
[TBL] [Abstract][Full Text] [Related]
29. Sphingosine-1-phosphate metabolism: A structural perspective.
Pulkoski-Gross MJ; Donaldson JC; Obeid LM
Crit Rev Biochem Mol Biol; 2015; 50(4):298-313. PubMed ID: 25923252
[TBL] [Abstract][Full Text] [Related]
30. Structure and function of sphingosine-1-phosphate lyase, a key enzyme of sphingolipid metabolism.
Bourquin F; Riezman H; Capitani G; Grütter MG
Structure; 2010 Aug; 18(8):1054-65. PubMed ID: 20696404
[TBL] [Abstract][Full Text] [Related]
31. Pharmacology of the sphingosine-1-phosphate signalling system.
Zu Heringdorf DM; Ihlefeld K; Pfeilschifter J
Handb Exp Pharmacol; 2013; (215):239-53. PubMed ID: 23579459
[TBL] [Abstract][Full Text] [Related]
32. Catalytic mechanism of 3-deoxy-D-manno-2-octulosonate-8-phosphate synthase. The use of synthetic analogues to probe the structure of the putative reaction intermediate.
Baasov T; Sheffer-Dee-Noor S; Kohen A; Jakob A; Belakhov V
Eur J Biochem; 1993 Nov; 217(3):991-9. PubMed ID: 8223657
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and evaluation of novel phosphate ester analogs as neutral sphingomyelinase inhibitors.
Imagawa H; Oda M; Takemoto T; Yamauchi R; Yoshikawa T; Yamamoto H; Nishizawa M; Takahashi H; Hashimoto M; Yabiku K; Nagahama M; Sakurai J
Bioorg Med Chem Lett; 2010 Jul; 20(13):3868-71. PubMed ID: 20627555
[TBL] [Abstract][Full Text] [Related]
34. Structures of Aquifex aeolicus KDO8P synthase in complex with R5P and PEP, and with a bisubstrate inhibitor: role of active site water in catalysis.
Wang J; Duewel HS; Woodard RW; Gatti DL
Biochemistry; 2001 Dec; 40(51):15676-83. PubMed ID: 11747443
[TBL] [Abstract][Full Text] [Related]
35. A Bioassay Using a Pentadecanal Derivative to Measure S1P Lyase Activity.
Shin KO; Shamshiddinova M; Lee JN; Lee KS; Lee YM
Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33535437
[TBL] [Abstract][Full Text] [Related]
36. Correction of lung inflammation in a F508del CFTR murine cystic fibrosis model by the sphingosine-1-phosphate lyase inhibitor LX2931.
Veltman M; Stolarczyk M; Radzioch D; Wojewodka G; De Sanctis JB; Dik WA; Dzyubachyk O; Oravecz T; de Kleer I; Scholte BJ
Am J Physiol Lung Cell Mol Physiol; 2016 Nov; 311(5):L1000-L1014. PubMed ID: 27663991
[TBL] [Abstract][Full Text] [Related]
37. Identification of the first mammalian sphingosine phosphate lyase gene and its functional expression in yeast.
Zhou J; Saba JD
Biochem Biophys Res Commun; 1998 Jan; 242(3):502-7. PubMed ID: 9464245
[TBL] [Abstract][Full Text] [Related]
38. Reduced Activity of Sphingosine-1-Phosphate Lyase Induces Podocyte-related Glomerular Proteinuria, Skin Irritation, and Platelet Activation.
Schümann J; Grevot A; Ledieu D; Wolf A; Schubart A; Piaia A; Sutter E; Côté S; Beerli C; Pognan F; Billich A; Moulin P; Walker UJ
Toxicol Pathol; 2015 Jul; 43(5):694-703. PubMed ID: 25630683
[TBL] [Abstract][Full Text] [Related]
39. A facile stable-isotope dilution method for determination of sphingosine phosphate lyase activity.
Suh JH; Eltanawy A; Rangan A; Saba JD
Chem Phys Lipids; 2016 Jan; 194():101-9. PubMed ID: 26408264
[TBL] [Abstract][Full Text] [Related]
40. Human sphingosine-1-phosphate lyase: cDNA cloning, functional expression studies and mapping to chromosome 10q22(1).
Van Veldhoven PP; Gijsbers S; Mannaerts GP; Vermeesch JR; Brys V
Biochim Biophys Acta; 2000 Sep; 1487(2-3):128-34. PubMed ID: 11018465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
